ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Many scientists would feel like slackers when faced with Y. Shrike Zhang's publication record. Only 32 years old, he already has more than 120 publications to his credit. And around 50 of those were published in 2016 and 2017 alone.
As a postdoctoral researcher in Ali Khademhosseini's lab at Harvard Medical School, Zhang led a subgroup of about 30 scientists—nearly a third of the overall lab. "He's the total package," says Khademhosseini, now at the University of California, Los Angeles. "He's not just good at science and writing papers, but he's also incredible at funding and handling larger operations. He's got that level of maturity fairly early."
Now with his own lab at Brigham & Women's Hospital and Harvard Medical School, Zhang develops model human tissues and organ mimics called organoids to predict people's responses to drugs and help personalize medicine. He focuses on improving every aspect of such systems, including the biofabrication techniques that grow the tissues, the microfluidics that supply them with nutrients, and the analytical methods needed to monitor their health.
Instead of just culturing cells, Zhang is working on direct printing of tissues with so-called bioinks—mixtures of cells and biomaterials that can be used in three-dimensional printers. The 3-D bioprinting lets him control where cells are deposited to build an organoid. "It's more robust and flexible, and it potentially gives you higher reproducibility," he says.
Zhang is meanwhile trying to bridge what he sees as a missing link in the organs-on-chips field: measurement technology. "People don't have many ways to look at how organoids are behaving or responding to drug molecules," he says. "We're developing a miniaturized microscope that can allow us to do 3-D imaging of organoids in a bioreactor. We can directly fit a small imager at the bottom of a bioreactor and look at how the organoids behave in three dimensions."
Khademhosseini expects Zhang to go far. "I'm confident he's going to do a lot of incredible things in the next 10 years," he says. "Many people just have a fairly constant, slightly upward-sloping trajectory. Shrike's trajectory is astronomical."
Current affiliation: Harvard Medical School and Brigham & Women's Hospital
Age: 32
Ph.D. alma mater: Georgia Institute of Technology & Emory University
If I weren't a chemist, I would be: A wildlife photographer. Nature and the creatures residing in it are simply amazing.
If I were an element, I would be: Hydrogen. It's leading the table.
Latest TV show binge-watched: Sports of all kinds
Walk up song: "Yang guang zong zai feng yu hou" (Sunshine after the rain) by Mavis Hsu
(Adv. Mater. 2018, DOI: 10.1002/adma.201800242)
(Proc. Natl. Acad. Sci. USA 2017, DOI: 10.1073/pnas.1612906114)
(Adv. Mater. 2016, DOI: 10.1002/adma.201604630)
Current affiliation: Harvard Medical School and Brigham & Women’s Hospital
Age: 32
Ph.D. alma mater: Georgia Institute of Technology & Emory University
If I weren’t a chemist, I would be: A wildlife photographer. Nature and the creatures residing in it are simply amazing.
If I were an element, I would be: Hydrogen. It’s leading the table.
Latest TV show binge-watched: Sports of all kinds
Walk-up song: “Yang guang zong zai feng yu hou” (Sunshine after the rain) by Mavis Hsu
“Microfluidics-Enabled Multi-Material Maskless Stereolithographic Bioprinting” (Adv. Mater. 2018, DOI: 10.1002/adma.201800242)
“Multisensor-Integrated Organs-on-Chips Platform for Automated and Continual In Situ Monitoring of Organoid Behaviors” (Proc. Natl. Acad. Sci. USA 2017, DOI: 10.1073/pnas.1612906114)
“Rapid Continuous Multimaterial Extrusion Bioprinting” (Adv. Mater. 2016, DOI: 10.1002/adma.201604630)
Many scientists would feel like slackers when faced with Y. Shrike Zhang’s publication record. Only 32 years old, he already has more than 120 publications to his credit. And around 50 of those were published in 2016 and 2017 alone.
As a postdoctoral researcher in Ali Khademhosseini’s lab at Harvard Medical School, Zhang led a subgroup of about 30 scientists—nearly a third of the overall lab. “He’s the total package,” says Khademhosseini, now at the University of California, Los Angeles. “He’s not just good at science and writing papers, but he’s also incredible at funding and handling larger operations. He’s got that level of maturity fairly early.”
Now with his own lab at Brigham & Women’s Hospital and Harvard Medical School, Zhang develops model human tissues and organ mimics called organoids to predict people’s responses to drugs and help personalize medicine. He focuses on improving every aspect of such systems, including the biofabrication techniques that grow the tissues, the microfluidics that supply them with nutrients, and the analytical methods needed to monitor their health.
Instead of just culturing cells, Zhang is working on direct printing of tissues with so-called bioinks—mixtures of cells and biomaterials that can be used in three-dimensional printers. The 3-D bioprinting lets him control where cells are deposited to build an organoid. “It’s more robust and flexible, and it potentially gives you higher reproducibility,” he says.
Zhang is meanwhile trying to bridge what he sees as a missing link in the organs-on-chips field: measurement technology. “People don’t have many ways to look at how organoids are behaving or responding to drug molecules,” he says. “We’re developing a miniaturized microscope that can allow us to do 3-D imaging of organoids in a bioreactor. We can directly fit a small imager at the bottom of a bioreactor and look at how the organoids behave in three dimensions.”
Khademhosseini expects Zhang to go far. “I’m confident he’s going to do a lot of incredible things in the next 10 years,” he says. “Many people just have a fairly constant, slightly upward-sloping trajectory. Shrike’s trajectory is astronomical.”
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X